COMMUNIQUÉS West-GlobeNewswire

Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019
13/08/2019
WALTHAM, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]
North American Partners in Anesthesia (NAPA) welcomes Dan Gofman as new Senior Vice President of Mergers & Acquisitions
13/08/2019
MELVILLE, N.Y., Aug. 13, 2019 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, today announced that Dan [...]
Better Choice Company Enters Research Agreement with Green Element to Test Anxiety-Reducing Potential in CBD Dog Treats
13/08/2019
NEW YORK, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company”), an animal health and wellness CBD company, today announced that the Company has entered into a research partnership [...]
Cleveland Clinic and Bravo Collaborate to Offer Wellness Program to Employers Nationwide
13/08/2019
CLEVELAND, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Cleveland Clinic and Bravo Wellness are collaborating to bring resources for employee wellness to employers and health plans nationwide. “After 10 years of innovation and [...]
Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board
13/08/2019
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
Precipio Announces Q2-2019 Corporate Update Call for Shareholders
13/08/2019
Conference Call to be held on Wednesday, August 21st, 2019 at 5:00 PM ET NEW HAVEN, Conn., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its [...]
BioNovelus Announces Removal of Yield Sign
13/08/2019
POTOMAC, Md., Aug. 13, 2019 (GLOBE NEWSWIRE) -- BioNovelus, Inc. (OTC: ONOV) announces it has submitted all necessary documentation, including its 2019 2Q report, to qualify as a “Pink Current” company on the OTC [...]
Imprivata Complements Microsoft Azure Experience with Day One Identity Management
13/08/2019
Imprivata Identity Governance is the front door to a secure and compliant digital identity strategy LEXINGTON, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, today introduced [...]
HealthEquity Sets Date to Announce Second Quarter Results Fiscal Year 2020
13/08/2019
Attend Investor Conferences DRAPER, Utah, Aug. 13, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (HSA) custodian, [...]
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
13/08/2019
San Diego, CA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 13,000,000 shares of its common [...]
Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
13/08/2019
CeD LA 3001 trial doses first patient in historic Phase 3 celiac disease trial RALEIGH, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage [...]
Strongbridge Biopharma Announces Key Leadership Appointments to Support Next Stage of Growth
13/08/2019
~ Richard S. Kollender Appointed to Chief Operating Officer ~ ~ Robert Lutz Promoted to Chief Financial Officer ~ ~ David Gill Appointed to Board of Directors ~ DUBLIN, Ireland and TREVOSE, Pa., Aug. 13, 2019 (GLOBE [...]
New IHIT Report Examines Hospital Cybersecurity Challenges and Identifies Next Steps in Protection
13/08/2019
How One Wrong Click Can Shut Down a Town ATLANTA, Aug. 13, 2019 (GLOBE NEWSWIRE) -- The statistics are staggering – and frightening: healthcare data breaches are currently being reported at a rate of more than one a day [...]
Ultragenyx to Present at Wedbush PacGrow Healthcare Conference
13/08/2019
NOVATO, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Aura Announces Pharmadrug Operational & Investor Relations Update
13/08/2019
TORONTO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) (CSE:BUZZ, OTCQB:LMLLF ) is pleased to provide an operational update on Pharmadrug Production GmbH (the “ German Business ” or “ [...]
Novan’s Phase 3 Molluscum Pivotal Program Completes Enrollment
13/08/2019
MORRISVILLE, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has recently completed patient recruitment in the Company’s ongoing “B-SIMPLE” ( [...]
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
13/08/2019
63% of evaluable subjects whose tumors had progressed during prior checkpoint inhibitor therapy benefited from treatment with the combination of pepinemab and avelumab Primary completion anticipated in second half of [...]
Hamilton Thorne Announces the Acquisition of Planer Ltd.
13/08/2019
Significantly expands expertise and product offerings in incubation, cryo-preservation and lab monitoring Provides a direct sales and support platform for the entire Hamilton Thorne product portfolio in the UK BEVERLY, [...]
iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer
13/08/2019
iTeos Therapeutics Announces Appointment of Matthew Call as Chief Operating Officer Gosselies, Belgium and Cambridge, MA – 13 August, 2019 – iTeos Therapeutics SA, a privately-held biotechnology company developing novel [...]

Pages